• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form F-10POS filed by Aphria Inc.

    5/4/21 6:15:47 AM ET
    $APHA
    Specialty Chemicals
    Consumer Durables
    Get the next $APHA alert in real time by email
    F-10POS 1 nt10023917x3_f10pos.htm F-10POS
    AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON MAY 4, 2021
    Registration Statement No. 333-250195
    Registration Statement No. 333-233426

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    POST-EFFECTIVE AMENDMENT NO. 1
    TO
    FORM F-10

    REGISTRATION STATEMENT
    UNDER
    THE SECURITIES ACT OF 1933

    Aphria Inc.
    (Exact name of Registrant as specified in its charter)

    Ontario, Canada
    (Province or other jurisdiction of incorporation or organization)

    2833
    (Primary Standard Industrial Classification Code Number (if applicable))

    Not Applicable
    (I.R.S. Employer Identification Number (if applicable))

    98 Talbot St. W.
    Leamington, Ontario N8H 1M8
    Canada
    (844) 427-4742
    (Address and telephone number of Registrant’s principal executive offices)

    CT Corporation System
    1015 15th Street N.W., Suite 1000
    Washington, DC 20005
    (202) 572-3100
    (Name, address (including zip code) and telephone number (including area code) of agent for service in the United States)

    Copies to:
    Christopher P. Giordano
    Jon Venick
    Stephen P. Alicanti
    DLA Piper LLP (US)
    1251 Avenue of the Americas
    New York, NY 10020
    (212) 335-4500

    Approximate date of commencement of proposed sale of the securities to the public:
    Not applicable.

    Province of Ontario, Canada
    (Principal jurisdiction regulating this offering)

    It is proposed that this filing shall become effective (check appropriate box):

    A.
    ☒ upon filing with the Commission, pursuant to Rule 467(a) (if in connection with an offering being made contemporaneously in the United States and Canada).

    B.
    ☐  at some future date (check the appropriate box below).


    1.   ☐
    pursuant to Rule 467(b) on ( ) at ( ) (designate a time not sooner than 7 calendar days after filing).


    2.   ☐
    pursuant to Rule 467(b) on ( ) at ( ) (designate a time 7 calendar days or sooner after filing) because the securities regulatory authority in the review jurisdiction has issued a receipt or notification of clearance on ( ).


    3.   ☐
    pursuant to Rule 467(b) as soon as practicable after notification of the Commission by the Registrant or the Canadian securities regulatory authority of the review jurisdiction that a receipt or notification of clearance has been issued with respect hereto.


    4.   ☐
    after the filing of the next amendment to this Form (if preliminary material is being filed).

    If any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to the home jurisdiction’s shelf prospectus offering procedures, check the following box. ☐





    EXPLANATORY NOTE

    DEREGISTRATION OF SECURITIES AND WITHDRAWAL OF REGISTRATION STATEMENT

    The Registrant initially filed the Registration Statement on Form F-10 (File No. 333-250195) with the Securities and Exchange Commission (the “SEC”) on November 19, 2020 (the “2020 Registration Statement”), which was declared effective on November 23, 2020. Pursuant to Rule 429 under the Securities Act of 1933, as amended, this Post-Effective Amendment No. 1 (this “Post-Effective Amendment”) also relates to the Registration Statement on Form F-10 (File No. 333-233426) with the SEC on August 23, 2019, as amended on November 13, 2019 and on November 22, 2019 (collectively, the “2019 Registration Statement” and, together with the 2020 Registration Statement, the “Registration Statements”), which was declared effective on November 26, 2019. The Registration Statements registered for sale an indeterminate number of securities, including common shares, warrants, subscription receipts, debt securities, convertible securities, rights and units (collectively, the “Securities”), with an aggregate initial offering price of USD$550,000,000.

    As previously publicly announced, the Registrant is party to an arrangement agreement, dated December 15, 2020, as amended on February 19, 2021, between the Registrant and Tilray, Inc. (“Tilray”), pursuant to which the Registrant and Tilray executed an arrangement (the “Arrangement”) under the Business Corporations Act (Ontario) on April 30, 2021 under the terms of which the Registrant and Tilray consummated transactions resulting in the combination of the Registrant and Tilray.

    In connection with the completion of the transactions contemplated by the Arrangement, the Registrant has terminated any and all offerings of its securities pursuant to the Registration Statements. This Post-Effective Amendment is being filed to deregister all of the Securities formerly issuable and registered under the Registration Statements and not otherwise sold by the Registrant as of the date hereof, and to discontinue the effectiveness of the Registration Statements.



    SIGNATURES OF APHRIA INC.

    Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-10 and has duly caused this Post-Effective Amendment No. 1 to the Registration Statements to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New York, State of New York, on May 4, 2021.

     
    APHRIA INC.

     
    By:
    /s/ IRWIN D. SIMON
       
    Name:
    Irwin D. Simon
       
    Title:
    Chief Executive Officer

    Pursuant to the requirements of the Securities Act of 1933, this Post-Effective Amendment No. 1 to the Registration Statements has been signed by the following persons in the following capacities on May 4, 2021.

    SIGNATURE
    TITLE
       
    /s/ IRWIN D. SIMON
    Chief Executive Officer and Chairman of the Board of Directors (Principal Executive Officer)
    Irwin D. Simon
     
       
    /s/ CARL A. MERTON
    Chief Financial Officer and Director (Principal Financial and Accounting Officer)
    Carl A. Merton
     
       
    /s/ DENISE M. FALTISCHEK
     Director
    Denise M. Faltischek
     



    AUTHORIZED REPRESENTATIVE

    Pursuant to the requirements of Section 6(a) of the Securities Act of 1933, the undersigned has signed this Post-Effective Amendment No. 1 to the Registration Statements, solely in the capacity of the duly authorized representative of the Registrant in the United States, on May 4, 2021.

     

    COGENCY GLOBAL INC.

     
    By:
    /s/ Colleen A. De Vries
       
    Name:
    Colleen A. De Vries
       
    Title:
    Sr. Vice President on behalf of Cogency Global Inc.


    Get the next $APHA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $APHA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $APHA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Cosmos Holdings Appoints Dr. Manfred Ziegler to its Advisory Board

      CHICAGO, IL / ACCESSWIRE / July 22 , 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, today announced that it has appointed finance veteran Dr. Manfred Ziegler to the Company's Advisory Board.Dr. Ziegler brings over 30 years of executive management, financial, and operational experience, as well as extensive expertise in mergers and acquisitions, with a particular focus on high-growth public and private companies. Notably, Dr. Manfred Ziegler served as Chief Executive Officer of CC Pharma, a l

      7/22/22 9:15:00 AM ET
      $COSM
      $APHA
      Other Pharmaceuticals
      Health Care
      Specialty Chemicals
      Consumer Durables
    • High Tide Continues Organic Growth with Two Stores in Alberta

      CALGARY, AB, June 1, 2021 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (TSXV:HITI) (OTCQB:HITID) (FRA:2LYA), a retail-focused cannabis corporation enhanced by the manufacturing and distribution of consumption accessories, announced today that its Alberta-based Canna Cabana retail stores located at 7400 Macleod Trail SE, Unit #2 in Calgary, and 4806 50 Avenue in Vegreville, have begun selling recreational cannabis products for adult use. These openings bring High Tide's total branded retail locations selling recreational cannabis products and consumption accessories across Canada to 87.  Staying true to High Tide's strategy of driving organic growth in profitable neighbourhood

      6/1/21 6:00:00 AM ET
      $APHA
      $ACB
      Specialty Chemicals
      Consumer Durables
      Medicinal Chemicals and Botanical Products
      Health Care
    • Nasdaq Approves High Tide's Application to List

      High Tide becomes the first major publicly traded cannabis retailer to announce it has been approved to trade on Nasdaq. High Tide shares expected to begin trading on Nasdaq on June 2nd, 2021 High Tide has received approval from Nasdaq to list its common shares for trading under the symbol "HITI" CALGARY, AB, May 28, 2021 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (TSXV:HITI) (OTCQB:HITID) (FRA: 2LYA), a retail-focused cannabis corporation enhanced by the manufacturing and distribution of consumption accessories, is pleased to announce that the Company's application to list its common shares ("Shares") on the Nasdaq Capital Market ("Nasdaq") has been approved. The Company

      5/28/21 6:00:00 AM ET
      $APHA
      $ACB
      Specialty Chemicals
      Consumer Durables
      Medicinal Chemicals and Botanical Products
      Health Care

    $APHA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Aphria downgraded by Canaccord Genuity

      Canaccord Genuity downgraded Aphria from Speculative Buy to Hold

      4/13/21 7:39:53 AM ET
      $APHA
      Specialty Chemicals
      Consumer Durables
    • Aphria downgraded by Canaccord Genuity with a new price target

      Canaccord Genuity downgraded Aphria from Speculative Buy to Hold and set a new price target of $17.50

      4/13/21 7:38:44 AM ET
      $APHA
      Specialty Chemicals
      Consumer Durables
    • CIBC reiterated coverage on Aphria with a new price target

      CIBC reiterated coverage of Aphria with a rating of Outperform and set a new price target of $28.00 from $18.00 previously

      2/22/21 12:33:35 PM ET
      $APHA
      Specialty Chemicals
      Consumer Durables

    $APHA
    Financials

    Live finance-specific insights

    See more
    • High Tide Acquires One of the Original Ontario Licensed Cannabis Retail Stores

      CALGARY, AB, April 29, 2021 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (TSXV:HITI) (OTCQB:HITIF) (FRA: 2LY), a retail-focused cannabis corporation enhanced by the manufacturing and distribution of consumption accessories, is pleased to announce that it has completed the acquisition (the "Transaction") of the Canna Cabana retail cannabis store located at 435(B) Yonge Street in Toronto, Ontario (the "Toronto Store"). The Toronto Store has a strong operating history, being one of the original 25 cannabis retail stores operating in the province. To date, High Tide has earned over $1 million in royalties from the Toronto Store.

      4/29/21 6:00:00 AM ET
      $APHA
      $ACB
      Specialty Chemicals
      Consumer Durables
      Medicinal Chemicals and Botanical Products
      Health Care
    • Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results

      Reports Eighth Consecutive Quarter of Positive Adjusted EBITDA and Positive Adjusted EBITDA from Cannabis Business LEAMINGTON, ON, April 12, 2021 /CNW/ - Aphria Inc. ("Aphria," "we," or the "Company") (TSX:APHA) (NASDAQ:APHA), a leading global cannabis-lifestyle consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today reported its financial results for the third quarter and nine months ended February 28, 2021. All amounts are expressed in Canadian dollars, unless otherwise noted and except for per gram, kilogram, kilogram equivalents, and per share amounts.

      4/12/21 7:00:00 AM ET
      $APHA
      Specialty Chemicals
      Consumer Durables
    • Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results

      Reports Eighth Consecutive Quarter of Positive Adjusted EBITDA and Positive Adjusted EBITDA from Cannabis Business LEAMINGTON, ON, April 12, 2021 /PRNewswire/ - Aphria Inc. ("Aphria," "we," or the "Company") (TSX:APHA) (NASDAQ:APHA), a leading global cannabis-lifestyle consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today reported its financial results for the third quarter and nine months ended February 28, 2021. All amounts are expressed in Canadian dollars, unless otherwise noted and except for per gram, kilogram, kilogram equivalents, and per share amounts.

      4/12/21 7:00:00 AM ET
      $APHA
      Specialty Chemicals
      Consumer Durables

    $APHA
    Leadership Updates

    Live Leadership Updates

    See more
    • Cosmos Holdings Appoints Dr. Manfred Ziegler to its Advisory Board

      CHICAGO, IL / ACCESSWIRE / July 22 , 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, today announced that it has appointed finance veteran Dr. Manfred Ziegler to the Company's Advisory Board.Dr. Ziegler brings over 30 years of executive management, financial, and operational experience, as well as extensive expertise in mergers and acquisitions, with a particular focus on high-growth public and private companies. Notably, Dr. Manfred Ziegler served as Chief Executive Officer of CC Pharma, a l

      7/22/22 9:15:00 AM ET
      $COSM
      $APHA
      Other Pharmaceuticals
      Health Care
      Specialty Chemicals
      Consumer Durables

    $APHA
    SEC Filings

    See more
    • SEC Form 15-12B filed by Aphria Inc.

      15-12B - Aphria Inc. (0001733418) (Filer)

      5/11/21 9:30:23 PM ET
      $APHA
      Specialty Chemicals
      Consumer Durables
    • SEC Form S-3ASR filed by Aphria Inc.

      S-3ASR - Aphria Inc. (0001733418) (Filer)

      5/6/21 5:30:37 PM ET
      $APHA
      Specialty Chemicals
      Consumer Durables
    • SEC Form 6-K filed by Aphria Inc.

      6-K - Aphria Inc. (0001733418) (Filer)

      5/4/21 6:17:37 AM ET
      $APHA
      Specialty Chemicals
      Consumer Durables